ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,362Medicare Part D Prescriptions Filled, Including Refills

Rank: 379 out of 1719

$795K Total Retail Price of All Prescriptions

Rank: 166 out of 1719

313 Patients Receiving at Least One Drug in Part D
75% Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Georgia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 313 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 313 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 378 320 63 1 4
OMEPRAZOLE 320 247 63 2 6
CLOPIDOGREL 221 174 33 3 18
PRAVASTATIN SODIUM 217 140 47 4 10
SIMVASTATIN 214 169 39 5 3
ZOLPIDEM TARTRATE 180 142 32 6 19
HYDROCODONE-ACETAMINOPHEN 177 152 33 S3 7 5
FENOFIBRATE* 172 93 33 8 47
METOPROLOL SUCCINATE 171 166* 29 9 26
HYDROCHLOROTHIAZIDE 169 134 37 10 11
AMLODIPINE BESYLATE 156 123 32 11 1
MELOXICAM 156 123 38 11 28
DONEPEZIL HCL 155 133 22 13 34
METFORMIN HCL 151 136 31 14 7
CLONAZEPAM 143 101 21 B 15 40
ATORVASTATIN CALCIUM 140 103 33 16 9
FUROSEMIDE 137 113 36 17 8
BENAZEPRIL HCL 129 124* 20 18 60
LISINOPRIL 129 90 32 18 2
POTASSIUM CHLORIDE 123 118* 28 20 15
CRESTOR 122 111 22 21 31
GABAPENTIN 121 83 26 22 12
TEMAZEPAM 117 99 24 B 23 94
TRAMADOL HCL 116 90 43 24 14
METOPROLOL TARTRATE 112 75 24 25 13
NEXIUM 111 79 17 26 24
ALPRAZOLAM 107 76 27 B 27 16
RANITIDINE HCL 106 80 23 28 23
ATENOLOL 98 93* 17 29 25
ESCITALOPRAM OXALATE 94 67 14 30 58
DIOVAN 91 73 11 31 49
MIRTAZAPINE 87 62 11 32 61
TRAZODONE HCL 85 68 17 33 38
METFORMIN HCL ER 83 65 15 34 52
CITALOPRAM HBR 80 26 14 35 22
ZETIA 80 64 15 35 76
BUSPIRONE HCL 79 51 14 37 118
NAMENDA 79 79 12 37 32
FLUTICASONE PROPIONATE 73 48 30 39 30
CARVEDILOL 71 37 12 40 20
CYMBALTA 69 33 12 41 51
JANUVIA 68 56 13 42 66
LOSARTAN POTASSIUM 68 68 16 42 17
NIASPAN 67 62* 13 44 140
CYCLOBENZAPRINE HCL 67 62* 23 R 44 62
VENLAFAXINE HCL ER 66 <11 <11 46 90
SYNTHROID 61 32 11 47 55
ISOSORBIDE MONONITRATE ER 60 <11 <11 48 77
CALCITONIN-SALMON 59 54* 17 49 352
ROPINIROLE HCL 58 35 11 50 80
FAMOTIDINE* 58 21 11 50 42
ALENDRONATE SODIUM 57 <11 <11 52 54
LOSARTAN-HYDROCHLOROTHIAZIDE 57 <11 <11 52 39
ALLOPURINOL 54 <11 <11 54 33
LANTUS 53 <11 <11 55 56
FENOFIBRATE* 52 <11 <11 56 47
BYSTOLIC 51 <11 <11 57 103
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.